| 1 |
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin, 2013, 63 (1): 11-30.
|
| 2 |
Hammond K, Margolin DA. The role of postoperative surveillance in colorectal cancer [J]. Clin Colon Rectal Surg, 2007, 20(3): 249-254.
|
| 3 |
Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial [J]. Lancet Oncol, 2013, 14(12): 1208-1215.
|
| 4 |
Hirai I, Kimura W, Fuse A, et al. Surgical management for metastatic liver tumors [J]. Hepatogastroenterology, 2006, 53(71): 757-763.
|
| 5 |
Schaefer O, Langer M. Detection of recurrent rectal cancer with CT, MRI and PET/CT [J]. Eur Radiol, 2007, 17(8): 2044-2054.
|
| 6 |
Maas M, Rutten IJ, Nelemans PJ, et al. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer [J]. Eur J Nucl Med Mol Imaging, 2011, 38(8): 1560-1571.
|
| 7 |
Lin JK, Lin CC, Yang SH, et al. Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer [J]. Int J Colorectal Dis, 2011, 26(9): 1135-1141.
|
| 8 |
Yakabe T, Nakafusa Y, Sumi K, et al. Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer [J]. Ann Surg Oncol, 2010, 17(9): 2349-2356.
|
| 9 |
Dirisamer A, Halpern BS, Flöry D, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT [J]. Eur J Radiol, 2010, 73(2): 324-328.
|
| 10 |
Wiering B, Vogel WV, Ruers TJ, et al. Controversies in the management of colorectal liver metastases: role of PET and PET/CT [J]. Dig Surg, 2008, 25(6): 413-420.
|
| 11 |
Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making [J]. Ann Oncol, 2012, 23(10): 2479-2516.
|
| 12 |
Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement [J]. J Clin Oncol, 2013, 31(35): 4465-4470.
|
| 13 |
Zhang C, Chen Y, Xue H, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis [J]. Int J Cancer, 2009, 124(1): 167-173.
|
| 14 |
Zhang Y, Feng B, Zhang GL, et al. Value of 18F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations [J]. World J Gastroenterol, 2014, 20(21): 6608-6614.
|
| 15 |
Panagiotidis E, Datseris IE, Rondogianni P, et al. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT? [J]. Nucl Med Commun, 2014, 35(6): 598-605.
|
| 16 |
Makis W, Kurzencwyg D, Hickeson M. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence [J]. Clin Imaging, 2013, 37(6): 1094-1097.
|
| 17 |
Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer [J]. Ann Surg, 2006, 244(2): 254-259.
|
| 18 |
Shamim SA, Kumar R, Halanaik D, et al. Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer [J]. Nucl Med Commun, 2010, 31(6): 590-596.
|
| 19 |
Kyoto Y, Momose M, Kondo C, et al. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations [J]. Ann Nucl Med, 2010, 24(5): 395-401.
|
| 20 |
Chiewvit S, Jiranantanakorn T, Apisarnthanarak P, et al. Detection of recurrent colorectal cancer by 18F-FDG PET/CT comparison with contrast enhanced CT scan [J]. J Med Assoc Thai, 2013, 96(6): 703-708.
|
| 21 |
Patel S, McCall M, Ohinmaa A, et al. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review [J]. Ann Surg, 2011, 253(4): 666-671.
|
| 22 |
Niekel MC, Bipat S, Stoker J, et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies includ- ing patients who have not previously undergone treatment [J]. Radiology, 2010, 257(3): 674-684.
|
| 23 |
Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 flurodeoxyglucose (FDG) PET scanning for pulmonary nodule less than 3cm in diameter, with special reference to the CT images. Lung Cancer, 2004, 45(1): 19-27.
|
| 24 |
Borasio P, Gisabella M, Billé A, et al. Role of surgical resection in colorectal lung metastases: analysis of 137 patients [J]. Int J Colorectal Dis, 2011, 26(2): 183-190.
|
| 25 |
Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer [J]. Cancer Investig, 2005, 23(4): 338-351.
|
| 26 |
Michael G, Magdalena K, Rune V. Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA [J]. Cancer Imaging, 2015, 13; 15: 11.
|
| 27 |
Sanli Y, Kuyumcu S, Ozkan ZG, et al. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer egardless of serum CEA levels [J]. Ann Nucl Med, 2012, 26(7): 551-558.
|
| 28 |
Chen LB, Tong JL, Song HZ, et al. (18)FDG PET/CT in detection of recurrence and metastasis of colorectal cancer [J]. World J Gastroenterol, 2007, 13(37): 5025-5029.
|
| 29 |
Ozkan E, Soydal C, Araz M, et al. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels [J]. Nucl Med Commun, 2012, 33(4): 395-402.
|
| 30 |
Han A, Xue J, Zhu D, et al. Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma [J]. Cancer Epidemiol, 2011, 35(5): 497-500.
|